Subtopic Deep Dive

Andrographolide Anti-Inflammatory Activity
Research Guide

What is Andrographolide Anti-Inflammatory Activity?

Andrographolide anti-inflammatory activity refers to the pharmacological effects of andrographolide, a diterpenoid lactone from Andrographis paniculata, in suppressing inflammation through NF-κB inhibition and cytokine modulation.

Studies demonstrate andrographolide inhibits NF-κB binding to DNA and reduces iNOS expression in macrophages (Hidalgo et al., 2005; Chiou et al., 2000). It prevents oxygen radical production in neutrophils and protects against LPS-induced lung injury (Shen et al., 2002; Zhu et al., 2013). Over 10 key papers from 2000-2020 document these mechanisms, with Shen et al. (2002) cited 354 times.

15
Curated Papers
3
Key Challenges

Why It Matters

Andrographolide offers NSAID alternatives for chronic inflammation in arthritis and sepsis by targeting NF-κB pathways, reducing cytokine storms as shown in LPS models (Zhu et al., 2013; Burgos et al., 2020). Clinical trials explore its use in flu and respiratory infections, with safety superior to some drugs (Silveira et al., 2020; Jayakumar et al., 2013). This addresses global burdens of inflammatory diseases, potentially lowering reliance on synthetic anti-inflammatories (Jantan et al., 2015).

Key Research Challenges

Translating Mechanisms to Clinics

Preclinical NF-κB inhibition in cell models requires human trials validation (Burgos et al., 2020). Dose-response inconsistencies across species limit translation (Jayakumar et al., 2013). Variability in bioavailability hinders efficacy prediction.

Pathway Specificity Confirmation

Distinguishing NF-κB from p38 MAPK/Nrf2 effects demands advanced signaling assays (Lee et al., 2013). iNOS suppression mechanisms overlap with radical scavenging, complicating attribution (Chiou et al., 2000). Multi-target nature challenges selective targeting.

Model Reproducibility Issues

Neutrophil and RAW 264.7 responses vary by endotoxin source (Shen et al., 2002). Lung injury models show dose-dependency but inconsistent IKKβ inhibition (Zhu et al., 2013). Standardized protocols are absent.

Essential Papers

1.

Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials

Ibrahim Jantan, Waqas Ahmad, Syed Nasir Abbas Bukhari · 2015 · Frontiers in Plant Science · 398 citations

The phagocyte-microbe interactions in the immune system is a defense mechanism but when excessively or inappropriately deployed can harm host tissues and participate in the development of different...

2.

Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti‐inflammatory effect

Yuh‐Chiang Shen, Chieh‐Fu Chen, Wen‐Fei Chiou · 2002 · British Journal of Pharmacology · 354 citations

We have reported that andrographolide (ANDRO), an active component of Andrographis paniculata , inhibits inflammatory responses by rat neutrophils. To further elucidate the possible mechanism(s) un...

3.

Experimental and Clinical Pharmacology of<i>Andrographis paniculata</i>and Its Major Bioactive Phytoconstituent Andrographolide

Thanasekaran Jayakumar, Cheng-Ying Hsieh, Jie-Jen Lee et al. · 2013 · Evidence-based Complementary and Alternative Medicine · 278 citations

Andrographis paniculata (Burm. F) Nees, generally known as “king of bitters,” is an herbaceous plant in the family Acanthaceae. In China, India, Thailand, and Malaysia, this plant has been widely u...

4.

COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Dâmaris Silveira, Jose Maria Prieto-Garcia, Fábio Boylan et al. · 2020 · Frontiers in Pharmacology · 268 citations

Our work suggests that several herbal medicines have safety margins superior to those of reference drugs and enough levels of evidence to start a clinical discussion about their potential use as ad...

5.

Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide

Wen‐Fei Chiou, Chieh‐Fu Chen, Jin‐Jung Lin · 2000 · British Journal of Pharmacology · 213 citations

Andrographolide, an active component found in leaves of Andrographis paniculata , has been reported to exhibit nitric oxide (NO) inhibitory property in endotoxin‐stimulated macrophages, however, th...

6.

Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB

Tao Zhu, Daoxin Wang, Wei Zhang et al. · 2013 · PLoS ONE · 209 citations

These results indicate that andrographolide dose-dependently suppressed the severity of LPS-induced ALI, more likely by virtue of andrographolide-mediated NF-κB inhibition at the level of IKKβ acti...

7.

Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism

Rafael A. Burgos, Pablo Alarcón, John Quiroga et al. · 2020 · Molecules · 163 citations

Andrographolide is a labdane diterpene and the main active ingredient isolated from the herb Andrographis paniculata. Andrographolide possesses diverse biological effects including anti-inflammator...

Reading Guide

Foundational Papers

Start with Shen et al. (2002, 354 citations) for neutrophil mechanisms and Chiou et al. (2000, 213 citations) for iNOS suppression, as they establish core anti-inflammatory assays. Follow with Hidalgo et al. (2005, 159 citations) and Zhu et al. (2013, 209 citations) for NF-κB specifics in relevant cells and models.

Recent Advances

Study Burgos et al. (2020, 163 citations) for metabolism links and Silveira et al. (2020, 268 citations) for COVID adjuvant evidence, highlighting translational advances.

Core Methods

Core techniques: Western blots for NF-κB/IKKβ, EMSA for DNA binding, Griess assays for NO/iNOS, ROS detection in neutrophils, and LPS-AL I histology (Shen 2002; Hidalgo 2005; Zhu 2013).

How PapersFlow Helps You Research Andrographolide Anti-Inflammatory Activity

Discover & Search

Research Agent uses searchPapers and citationGraph to map NF-κB inhibition papers from Shen et al. (2002, 354 citations), revealing clusters around Hidalgo et al. (2005) and Zhu et al. (2013). exaSearch uncovers preclinical immunomodulator reviews like Jantan et al. (2015). findSimilarPapers expands from Burgos et al. (2020) to metabolism-linked anti-inflammatory effects.

Analyze & Verify

Analysis Agent employs readPaperContent on Zhu et al. (2013) to extract IKKβ data, then runPythonAnalysis for dose-response curve fitting with matplotlib on LPS-AL I metrics. verifyResponse (CoVe) cross-checks NF-κB claims against Chiou et al. (2000), achieving GRADE B evidence grading for iNOS suppression reproducibility.

Synthesize & Write

Synthesis Agent detects gaps in clinical translation from Jayakumar et al. (2013), flagging cytokine modulation voids. Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 10 papers, and latexCompile for review manuscripts. exportMermaid visualizes NF-κB → iNOS cascades from Hidalgo et al. (2005).

Use Cases

"Plot dose-response of andrographolide on NF-κB inhibition from LPS lung injury papers"

Research Agent → searchPapers('andrographolide NF-κB LPS') → Analysis Agent → readPaperContent(Zhu 2013) → runPythonAnalysis(pandas curve_fit on IKKβ data) → matplotlib plot of IC50 values.

"Write LaTeX review on andrographolide neutrophil mechanisms citing Shen 2002"

Research Agent → citationGraph(Shen 2002) → Synthesis Agent → gap detection → Writing Agent → latexEditText(structured review) → latexSyncCitations(10 papers) → latexCompile(PDF with NF-κB figure).

"Find code for andrographolide iNOS simulation models"

Research Agent → paperExtractUrls(Chiou 2000) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(NumPy repro of RAW 264.7 NO kinetics).

Automated Workflows

Deep Research workflow conducts systematic review of 50+ andrographolide papers via searchPapers → citationGraph → GRADE grading, producing structured reports on NF-κB pathways (e.g., Hidalgo 2005). DeepScan applies 7-step CoVe analysis to verify iNOS claims from Chiou et al. (2000) against neutrophil data (Shen 2002). Theorizer generates hypotheses linking metabolism modulation (Burgos 2020) to cytokine control.

Frequently Asked Questions

What defines andrographolide anti-inflammatory activity?

It encompasses NF-κB inhibition, iNOS suppression, and oxygen radical reduction in neutrophils and macrophages (Shen et al., 2002; Chiou et al., 2000).

What are key methods in this research?

Methods include LPS-stimulated RAW 264.7 cells for iNOS assays, HL-60 neutrophilic cells for NF-κB DNA binding, and ALI mouse models for pathway validation (Chiou et al., 2000; Hidalgo et al., 2005; Zhu et al., 2013).

What are the highest-cited papers?

Shen et al. (2002, 354 citations) on neutrophil radicals; Jayakumar et al. (2013, 278 citations) on pharmacology; Chiou et al. (2000, 213 citations) on iNOS mechanisms.

What open problems exist?

Challenges include clinical dosing from preclinical NF-κB data, pathway crosstalk resolution, and standardized inflammation models across studies (Burgos et al., 2020; Jantan et al., 2015).

Research Andrographolide Research and Applications with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Andrographolide Anti-Inflammatory Activity with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers